The Framingham Heart Study is the longest running cohort study on cardiovascular health in human history. Last fall, the study turned 75 — we speak with two generations of participants and the ...

Though the risk of cardiovascular disease and death rates dropped by about 75% between the 1950s and 2010, the reduction hasn’t kept up since, said Dr. David Goff, NIH director at the Division ...

Framingham cardiovascular risk prediction model from the 1990s still gives the best results Download PDF Copy Reviewed by James Ives, M.Psych. (Editor) Mar 19 2019 ...

Framingham General Cardiovascular Risk Score and cognitive impairment: the power of foresight. J Am Coll Cardiol. 2020;75(20):2535-2537. doi: 10.1016/j.jacc.2020.03.061 ...

Fifty-five years of data from the Framingham Heart Study show that all-cause and cardiovascular disease deaths have indeed declined since 1950 in men and women with and without diabetes mellitus.

Novo Nordisk’s Wegovy, part of the booming group of drugs called GLP-1 receptor agonists, was shown to reduce those people’s risk of another cardiovascular event by 20%, results that were ...

Higher cardiovascular morbidity was associated with more severe urge urinary incontinence and worse quality of life. Women at high cardiovascular (CV) risk may benefit less from anticholinergics ...